Jinfang Zheng

Anlotinib plus penpulimab versus sorafenib in the eerstelijns treatment of unresectable hepatocellular carcinoma (APO...

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non...